Mitsuhiko Iwamoto

734 total citations
42 papers, 540 citations indexed

About

Mitsuhiko Iwamoto is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Mitsuhiko Iwamoto has authored 42 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 15 papers in Cancer Research and 12 papers in Surgery. Recurrent topics in Mitsuhiko Iwamoto's work include Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Treatment and Pharmacology (9 papers). Mitsuhiko Iwamoto is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Treatment and Pharmacology (9 papers). Mitsuhiko Iwamoto collaborates with scholars based in Japan and United States. Mitsuhiko Iwamoto's co-authors include Nobuhiko Tanigawa, Takehiro Nohara, Hideaki Mabuchi, Akiko Miyamoto, Satoru Tanaka, Masao Toyoda, Goki Gon, Hisashi Shinohara, Yoshiharu Miyamoto and Yuko Takahashi and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Mitsuhiko Iwamoto

35 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitsuhiko Iwamoto Japan	11	258	151	136	132	101	42	540
Chiara Intrivici Italy	13	271 1.1×	228 1.5×	173 1.3×	113 0.9×	124 1.2×	20	604
Kathrin Glatz Switzerland	8	336 1.3×	83 0.5×	128 0.9×	118 0.9×	50 0.5×	12	581
Christian Teschendorf Germany	12	222 0.9×	75 0.5×	75 0.6×	125 0.9×	58 0.6×	28	621
Masato Sugano Japan	13	427 1.7×	135 0.9×	107 0.8×	236 1.8×	117 1.2×	44	709
Warner Alpízar‐Alpízar Costa Rica	12	151 0.6×	119 0.8×	154 1.1×	101 0.8×	132 1.3×	26	407
Jiemin Zhao China	12	612 2.4×	368 2.4×	115 0.8×	187 1.4×	137 1.4×	28	856
Marie Alt France	11	543 2.1×	148 1.0×	119 0.9×	256 1.9×	160 1.6×	20	748
Albiruni Abdul Razak Canada	12	425 1.6×	108 0.7×	132 1.0×	267 2.0×	98 1.0×	37	726
María Gómez Galdón Belgium	14	487 1.9×	55 0.4×	225 1.7×	156 1.2×	172 1.7×	31	732
Michele Prisciandaro Italy	15	566 2.2×	102 0.7×	119 0.9×	270 2.0×	146 1.4×	49	761

Countries citing papers authored by Mitsuhiko Iwamoto

Since Specialization

Citations

This map shows the geographic impact of Mitsuhiko Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuhiko Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuhiko Iwamoto more than expected).

Fields of papers citing papers by Mitsuhiko Iwamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuhiko Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuhiko Iwamoto. The network helps show where Mitsuhiko Iwamoto may publish in the future.

Co-authorship network of co-authors of Mitsuhiko Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuhiko Iwamoto. A scholar is included among the top collaborators of Mitsuhiko Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuhiko Iwamoto. Mitsuhiko Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Rongrong, Kohei Taniguchi, Brian Morreale, et al.. (2025). ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer. Annals of Surgical Oncology. 33(1). 758–768.

Ito, Yuko, et al.. (2024). Role of CD44-Positive Extracellular Vesicles Derived from Highly Metastatic Mouse Mammary Carcinoma Cells in Pre-Metastatic Niche Formation. International Journal of Molecular Sciences. 25(17). 9742–9742. 3 indexed citations

Neo, Masashi, et al.. (2023). Preventive effect of dexamethasone premedication on the development of infusion‐related reaction in breast cancer patients receiving trastuzumab. British Journal of Clinical Pharmacology. 89(7). 2102–2112. 2 indexed citations

Kawabata, Shigeru, Tomo Tominaga, M. Tanaka, et al.. (2022). Breast neuroendocrine tumor arising in the axilla of a man: a case report. Journal of Medical Case Reports. 16(1). 467–467. 1 indexed citations

Masuda, Norikazu, Tetsuhiro Yoshinami, Masahiko Ikeda, et al.. (2021). Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214. Cancers. 13(17). 4399–4399. 1 indexed citations

Yoshioka, Hiroto, Chikara Sato, Akihiro Hori, et al.. (2021). New enzyme‑targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer. Molecular and Clinical Oncology. 15(5). 241–241. 7 indexed citations

Iwamoto, Mitsuhiko, Satoru Tanaka, Daigo Yamamoto, et al.. (2018). A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes. Cancer Chemotherapy and Pharmacology. 81(5). 923–933. 8 indexed citations

Sakai, Akiko, et al.. (2016). Comparative proteomic analysis of paclitaxel resistance-related proteins in human breast cancer cell lines. Oncology Letters. 13(1). 289–295. 13 indexed citations

Tanaka, Satoru, et al.. (2016). A Phase II Study of Adjuvant Chemotherapy of Tegafur–Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant Chemotherapy. Anticancer Research. 36(12). 6505–6510. 5 indexed citations

10.

Tanaka, Satoru, et al.. (2016). Outpatient management without initial assessment for febrile patients undergoing adjuvant chemotherapy for breast cancer. Molecular and Clinical Oncology. 5(4). 385–390.

11.

Tanaka, Satoru, Mitsuhiko Iwamoto, Katsuhide Yoshidome, et al.. (2014). Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer. Clinical Breast Cancer. 15(3). 191–196. 29 indexed citations

12.

Tanaka, Satoru, et al.. (2011). Esthetic result of rhomboid flap repair after breast-conserving surgery for lower quadrant breast cancer lesion with skin invasion: Report of two cases. Surgery Today. 41(6). 832–836. 5 indexed citations

13.

Hirokawa, Fumitoshi, Michihiro Hayashi, Yoshiharu Miyamoto, et al.. (2010). A novel method using the VIO soft-coagulation system for liver resection. Surgery. 149(3). 438–444. 46 indexed citations

14.

Nohara, Takehiro, Mitsuhiko Iwamoto, Satoru Tanaka, et al.. (2010). Usefulness of intraoperative touch smear cytology in breast-conserving surgery. Experimental and Therapeutic Medicine. 1(4). 641–645. 12 indexed citations

15.

Tanigawa, Nobuhiko, Mitsuru Matsuki, Takehiro Nohara, et al.. (2009). High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results. Breast Cancer. 17(4). 241–246. 29 indexed citations

16.

Inoué, Yoshihiro, et al.. (2008). A CASE OF BREAST CARCINOMA ARISING IN CONGENITAL DEFECT OF THE PECTORALIS MUSCLES. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(11). 2799–2803. 1 indexed citations

17.

Tanaka, Satoru, et al.. (2008). Tau expression and efficacy of paclitaxel treatment in metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 64(2). 341–346. 34 indexed citations

18.

Shibayama, Yuro, Takehiro Nohara, Mitsuhiko Iwamoto, et al.. (2006). Detection of human epidermal growth factor receptor 2 protein and gene in fine needle aspiration cytology specimens and tissue sections from invasive breast cancer: Can cytology specimens take the place of tissue sections?. Oncology Reports. 15(4). 803–8. 19 indexed citations

19.

Nohara, Takehiro, et al.. (2003). [Examination of therapy using trastuzumab in patients with metastatic breast carcinoma].. PubMed. 30(11). 1651–4. 1 indexed citations

20.

Tokuhara, Takaya, et al.. (2002). A Case of Colonic Cancer with Heterochronous Solitary Adrenal Metastasis.. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 63(11). 2747–2751. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact